445 related articles for article (PubMed ID: 19320394)
1. [Non-invasive molecular detection of bladder cancer].
Hatachmi S
Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers for detection, surveillance and prognostication of bladder cancer.
Vrooman OP; Witjes JA
Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346
[TBL] [Abstract][Full Text] [Related]
3. [Bladder cancer biomarkers].
Dobrowolska-Glazar B; Glazar W; Dobrowolski Z; Lipczyński W
Przegl Lek; 2010; 67(7):479-83. PubMed ID: 21387760
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic aspects of bladder cancer.
Kim WJ; Quan C
J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
[TBL] [Abstract][Full Text] [Related]
6. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.
Sanchez-Carbayo M; Socci ND; Lozano J; Saint F; Cordon-Cardo C
J Clin Oncol; 2006 Feb; 24(5):778-89. PubMed ID: 16432078
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
8. Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer.
Lintula S; Hotakainen K
Expert Opin Biol Ther; 2010 Aug; 10(8):1169-80. PubMed ID: 20446896
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of invasive bladder cancers: histological and molecular markers.
Liebert M; Seigne J
Semin Urol Oncol; 1996 May; 14(2):62-72. PubMed ID: 8734733
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Knowles MA
Carcinogenesis; 2006 Mar; 27(3):361-73. PubMed ID: 16352616
[TBL] [Abstract][Full Text] [Related]
11. Bladder cancer in 2010: how far have we come?
Jacobs BL; Lee CT; Montie JE
CA Cancer J Clin; 2010; 60(4):244-72. PubMed ID: 20566675
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
Sugano K; Kakizoe T
Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
[TBL] [Abstract][Full Text] [Related]
14. Comparative promoter methylation analysis of p53 target genes in urogenital cancers.
Christoph F; Hinz S; Weikert S; Kempkensteffen C; Schostak M; Miller K; Schrader M
Urol Int; 2008; 80(4):398-404. PubMed ID: 18587251
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in muscle invasive bladder cancer.
Tiguert R; Lessard A; So A; Fradet Y
World J Urol; 2002 Aug; 20(3):190-5. PubMed ID: 12196903
[TBL] [Abstract][Full Text] [Related]
16. Gene signatures for risk-adapted treatment of bladder cancer.
Ørntoft TF; Dyrskjøt L
Scand J Urol Nephrol Suppl; 2008 Sep; (218):166-74. PubMed ID: 18815931
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
18. Potential of urinary biomarkers in early bladder cancer diagnosis.
Lam T; Nabi G
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer diagnosis and recurrence prognosis: comparison of markers with emphasis on survivin.
Schultz IJ; Witjes JA; Swinkels DW; de Kok JB
Clin Chim Acta; 2006 Jun; 368(1-2):20-32. PubMed ID: 16480698
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of bladder cancer.
Mitra AP; Datar RH; Cote RJ
BJU Int; 2005 Jul; 96(1):7-12. PubMed ID: 15963111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
